Clinical trial
Efficacy of Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint
NCT07078006 is registered in ClinicalTrials.gov with Nasser Institute For Research and Treatment as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint
- Lead sponsor
- Nasser Institute For Research and Treatment
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 22, 2023
- Completion date
- July 23, 2024
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative temporomandibular joint, platelet rich fibrin, platelet rich plasma injection